抗药性
抗癌药物
癌细胞系
抗性(生态学)
癌症
医学
药品
癌细胞
药理学
生物
遗传学
内科学
生态学
作者
Cristina P. R. Xavier,Milica Pešić,M. Helena Vasconcelos
出处
期刊:Current Cancer Drug Targets
[Bentham Science]
日期:2016-02-06
卷期号:16 (3): 226-237
被引量:35
标识
DOI:10.2174/1568009616666151113120705
摘要
Despite the enormous number of anticancer drugs presently available in the clinic, treatment failure due to drug resistance is very frequent. The identification of mechanisms of resistance to different drugs is necessary, in order to identify ways to prevent and circumvent such resistance. Indeed, the identification of novel therapeutic targets to overcome cancer drug resistance remains one of the major challenges in drug discovery and development. The methods employed to identify drug resistance mechanisms and novel therapeutic targets depend greatly on the establishment of cancer drug resistant cell lines. The establishment of such drug resistant cell lines is laborious and time-consuming and various different approaches have been described. This manuscript reviews the methodologies that have been used to create cancer drug resistant cell lines and to identify their mechanisms of resistance. In addition, this review highlights the most frequent drug resistance mechanisms found in cancer cells. Keywords: Acquired drug resistance, anticancer drugs, cancer drug resistance, drug resistant cancer cell lines, isogenic cell lines, mechanisms of drug resistance, multidrug resistance.
科研通智能强力驱动
Strongly Powered by AbleSci AI